Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.44 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.44 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.44 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.44 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.44 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.44 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.44 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.44 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.44 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.44 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.44 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.44 |
| ▸ | PSMB10 | P40306 | 2/20 | 0.44 |
| ▸ | PSMB3 | P49720 | 2/20 | 0.44 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.44 |
| ▸ | PSMA6 | P60900 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16311230 | 0.84 | CYP1A2 (0.50) | CYP1A1GAAPOLBALDH1A1MAPT | |
| SCHEMBL14918751 | 0.82 | POLB (0.39) | CYP1A1HDAC4POLBMEN1CYP3A4 | |
| SCHEMBL27937384 | 0.80 | CYP1A1 (0.84) | CYP1A1TRPV1GAAPSMB11PSMA7 | |
| SCHEMBL13804328 | 0.79 | CNR2 (0.66) | CYP1A1TRPV1GAAPSMB11PSMA7 | |
| SCHEMBL18897622 | 0.74 | HDAC4 (0.59) | HDAC4CYP3A4CYP1A2BRD4NR1I2 | |
| SCHEMBL31203439 | 0.73 | HDAC4 (0.62) | HDAC4CYP3A4BRD4NR1I2HDAC3 | |
| SCHEMBL31203346 | 0.73 | HDAC4 (0.62) | HDAC4CYP3A4BRD4NR1I2HDAC3 | |
| SCHEMBL31203361 | 0.73 | HDAC4 (0.62) | HDAC4CYP3A4BRD4NR1I2HDAC3 | |
| SCHEMBL19150356 | 0.73 | CYP1A1 (0.67) | CYP1A1TRPV1GAAPSMB11PSMA7 | |
| SCHEMBL2205077 | 0.73 | CYP1A1 (0.67) | CYP1A1TRPV1GAAPSMB11PSMA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11944618-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | SERINA THERAPEUTICS, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-20220354841-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | US | disclosed |
| US-11298350-B2 | Subcutaneous delivery of polymer conjugates of therapeutics agents | SERINA THERAPEUTICS, INC. (US) | 2022-04-12 | — | — | US | disclosed |
| US-20200093816-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTICS AGENTS | SERINA THERAPEUTICS (AL), INC. | 2020-03-26 | — | — | US | disclosed |
| US-20200093816-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTICS AGENTS | SERINA THERAPEUTICS (AL), INC. | 2020-03-26 | — | — | US | disclosed |
| EP-2773379-B1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS INC (US) | 2019-10-09 | — | — | EP | disclosed |
| EP-2773379-B1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS INC (US) | 2019-10-09 | — | — | EP | disclosed |
| US-10426768-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | Sarina Therapeutics, Inc. (US) | 2019-10-01 | — | — | US | disclosed |
| US-10426768-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | Sarina Therapeutics, Inc. (US) | 2019-10-01 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS (AL), INC. | 2017-07-20 | — | — | US | disclosed |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2773379-A2 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | Serina Therapeutics, Inc. (US) | 2014-09-10 | — | — | EP | disclosed |
| WO-2013067199-A2 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | SERINA THERAPEUTICS, INC. (US) | 2013-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426768-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | CD44, CD47, LNPEP | CYP1A1 4638/4885TRPV1 4845/4885GAA 229/4885 |
| US-11944618-B2 | Subcutaneous delivery of polymer conjugates of therapeutic agents | CD44, CD47, LNPEP | CYP1A1 4670/4885TRPV1 4847/4885GAA 283/4885 |
| US-20170202972-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | CD44, CD47, LNPEP | CYP1A1 4638/4885TRPV1 4845/4885GAA 229/4885 |
| US-20200093816-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTICS AGENTS | CD44, CD47, LNPEP | CYP1A1 4469/4885TRPV1 4824/4885GAA 108/4885 |
| US-20140271527-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | CD44, CD47, LNPEP | CYP1A1 4638/4885TRPV1 4845/4885GAA 229/4885 |
| US-11298350-B2 | Subcutaneous delivery of polymer conjugates of therapeutics agents | CD44, CD47, LNPEP | CYP1A1 4469/4885TRPV1 4824/4885GAA 108/4885 |
| US-20220354841-A1 | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS | CD44, CD47, LNPEP | CYP1A1 4638/4885TRPV1 4845/4885GAA 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.